跳至主要内容
临床试验/ACTRN12624001019594
ACTRN12624001019594尚未招募Unknown

Type 2 diabetes and metabolic syndrome remission program, a co-designed stepped wedge pilot with Aboriginal people living on Ngarrindjeri Country – ‘Nra:gi Ya:yun’ (healthy foods)

Flinders University0 个研究点目标入组 120 人开始时间: 2024年8月22日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Aboriginal person living on Ngarrindjeri country, aged 18 years or over, records measurements consistent with type 2 diabetes (HbA1c levels greater than or equal to 6.5%A1c) or metabolic syndrome (defined by meeting 3 of 5: abdominal obesity, hypertension, insulin resistance, raised triglycerides, decreased HDL cholesterol).

排除标准

  • *Pregnancy
  • *breast feeding women
  • *Type 1 diabetes
  • *End stage liver failure or undergoing dialysis
  • *T3cD (primary pancreatic disease)
  • *Insulin deficient diabetes
  • *self-reported eating disorders (anorexia, nervosa, bulimia)
  • *On SGLT2 inhibitors for reasons other than diabetes (i.e. renal disease or heart failure)

研究者

相似试验

Type 2 diabetes and metabolic syndrome remission... | 临床试验